These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 6991405)

  • 21. Plasmid-mediated carbapenem-hydrolysing β-lactamase KPC-2 in a Klebsiella pneumoniae isolate from Switzerland.
    Poirel L; Lienhard R; Potron A; Malinverni R; Siegrist HH; Nordmann P
    J Antimicrob Chemother; 2011 Mar; 66(3):675-6. PubMed ID: 21193473
    [No Abstract]   [Full Text] [Related]  

  • 22. Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature.
    Elemam A; Rahimian J; Mandell W
    Clin Infect Dis; 2009 Jul; 49(2):271-4. PubMed ID: 19527172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae.
    Meletis G; Tzampaz E; Sianou E; Tzavaras I; Sofianou D
    J Antimicrob Chemother; 2011 Apr; 66(4):946-7. PubMed ID: 21393203
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of porin loss on the activity of tigecycline against Klebsiella pneumoniae producing extended-spectrum beta-lactamases or plasmid-mediated AmpC-type beta-lactamases.
    Conejo MC; Hernández JR; Pascual A
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):343-5. PubMed ID: 18339509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Klebocin types & antimicrobial resistance of clinical isolates of Klebsiella pneumoniae at Bombay.
    Telang VP; Rangnekar VM; Banker DD
    Indian J Med Res; 1983 Sep; 78():331-6. PubMed ID: 6370848
    [No Abstract]   [Full Text] [Related]  

  • 26. Organic solvent tolerance and fluoroquinolone resistance in Klebsiella pneumoniae clinical isolates.
    Aathithan S; French GL
    J Antimicrob Chemother; 2009 Oct; 64(4):870-1. PubMed ID: 19679596
    [No Abstract]   [Full Text] [Related]  

  • 27. [Resistance of Klebsiella pneumoniae to drugs].
    Jiang H
    Zhonghua Yi Xue Za Zhi; 1990 Feb; 70(2):101-4. PubMed ID: 2161265
    [No Abstract]   [Full Text] [Related]  

  • 28. Susceptibility of Klebsiella pneumoniae clinical isolates from 2007 to 2009 to colistin and comparator antibiotics.
    Hawser SP
    Int J Antimicrob Agents; 2010 Oct; 36(4):383-4. PubMed ID: 20674285
    [No Abstract]   [Full Text] [Related]  

  • 29. [Epidemiological relation between Klebsiella pneumoniae isolated from feces and from hospital urinary infections].
    Pereira JA; Suassuna I
    Rev Latinoam Microbiol; 1986; 28(3):201-9. PubMed ID: 3296072
    [No Abstract]   [Full Text] [Related]  

  • 30. Multidrug resistance determinants from NDM-1-producing Klebsiella pneumoniae in the USA.
    Leski T; Vora GJ; Taitt CR
    Int J Antimicrob Agents; 2012 Sep; 40(3):282-4. PubMed ID: 22817914
    [No Abstract]   [Full Text] [Related]  

  • 31. Oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Lebanon.
    Matar GM; Cuzon G; Araj GF; Naas T; Corkill J; Kattar MM; Nordmann P
    Clin Microbiol Infect; 2008 Sep; 14(9):887-8. PubMed ID: 18844693
    [No Abstract]   [Full Text] [Related]  

  • 32. Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae.
    Pankey GA; Ashcraft DS
    Diagn Microbiol Infect Dis; 2011 Aug; 70(4):561-4. PubMed ID: 21767715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of the Etest method for fosfomycin susceptibility of ESBL-producing Klebsiella pneumoniae.
    López-Cerero L; de Cueto M; Díaz-Guerrero MA; Morillo C; Pascual A
    J Antimicrob Chemother; 2007 Apr; 59(4):810-2. PubMed ID: 17289760
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalence of 16S rRNA methylase genes in Klebsiella pneumoniae isolates from a Chinese teaching hospital: coexistence of rmtB and armA genes in the same isolate.
    Yu F; Wang L; Pan J; Yao D; Chen C; Zhu T; Lou Q; Hu J; Wu Y; Zhang X; Chen Z; Qu D
    Diagn Microbiol Infect Dis; 2009 May; 64(1):57-63. PubMed ID: 19232867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of CLSI 2009, CLSI 2010 and EUCAST cephalosporin clinical breakpoints in recent clinical isolates of Escherichia coli, Klebsiella pneumoniae and Klebsiella oxytoca from the SMART Global Surveillance Study.
    Hawser SP; Badal RE; Bouchillon SK; Hoban DJ; Hsueh PR
    Int J Antimicrob Agents; 2010 Sep; 36(3):293-4. PubMed ID: 20598511
    [No Abstract]   [Full Text] [Related]  

  • 36. [Protective effects of bacterial immunostimulants in mice infected by "Klebsiella pneumoniae" resistant to antibiotics after mutation or by plasmid transfer].
    Parant M; Parant F; Chedid L; Minor LL
    Ann Immunol (Paris); 1975 Apr; 126(3):319-26. PubMed ID: 1101801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emergence of resistance to fosfomycin used as adjunct therapy in KPC Klebsiella pneumoniae bacteraemia: report of three cases.
    Karageorgopoulos DE; Miriagou V; Tzouvelekis LS; Spyridopoulou K; Daikos GL
    J Antimicrob Chemother; 2012 Nov; 67(11):2777-9. PubMed ID: 22782489
    [No Abstract]   [Full Text] [Related]  

  • 38. First case of resistance to tigecycline by Klebsiella pneumoniae in a European University Hospital.
    Neonakis IK; Stylianou K; Daphnis E; Maraki S
    Indian J Med Microbiol; 2011; 29(1):78-9. PubMed ID: 21304206
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of porins and plasmid-mediated AmpC beta-lactamases on the efficacy of beta-lactams in rat pneumonia caused by Klebsiella pneumoniae.
    Padilla E; Alonso D; Doménech-Sánchez A; Gomez C; Pérez JL; Albertí S; Borrell N
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2258-60. PubMed ID: 16723600
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diverse phenotypic and genotypic characterization among clinical Klebsiella pneumoniae and Escherichia coli isolates carrying plasmid-mediated quinolone resistance determinants.
    Yang J; Luo Y; Cui S; Wang W; Han L
    Microb Drug Resist; 2011 Sep; 17(3):363-7. PubMed ID: 21563956
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.